{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:27:24Z","timestamp":1792463244601,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["KLI 1188"],"award-info":[{"award-number":["KLI 1188"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jiph.2025.102698","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T12:15:38Z","timestamp":1739189738000},"page":"102698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["COVID-19 case fatality rate and infection fatality rate from 2020 to 2023: Nationwide analysis in Austria"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2541-9604","authenticated-orcid":false,"given":"Uwe","family":"Riedmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Chalupka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sprenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Willeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Schennach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Benka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Werber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Beth","family":"H\u00f8eg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John PA","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2025.102698_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13782","article-title":"The end of the COVID-19 pandemic","volume":"52","author":"Ioannidis","year":"2022","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.jiph.2025.102698_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5582\/bst.2023.01124","article-title":"The priority for prevention and control of infectious diseases: reform of the centers for disease prevention and control \u2013 occasioned by \u201cthe WHO chief declares end to COVID-19 as a global health emergency","volume":"17","author":"Luo","year":"2023","journal-title":"Biosci Trends"},{"key":"10.1016\/j.jiph.2025.102698_bib3","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(20)32007-9","article-title":"Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe","volume":"396","author":"Han","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2025.102698_bib4","doi-asserted-by":"crossref","unstructured":"Murphy C., Lim W.W., Mills C., Wong J.Y., Chen D., Xie Y., et al. Effectiveness of social distancing measures and lockdowns for reducing transmission of COVID-19 in non-healthcare, community-based settings. Philos Trans A Math Phys Eng Sci n.d.;381:20230132. https:\/\/doi.org\/10.1098\/rsta.2023.0132.","DOI":"10.1098\/rsta.2023.0132"},{"key":"10.1016\/j.jiph.2025.102698_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12889-023-15112-0","article-title":"High variability of COVID-19 case fatality rate in Germany","volume":"23","author":"Wjst","year":"2023","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.jiph.2025.102698_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08869-7","article-title":"Changes in the intrinsic severity of severe acute respiratory syndrome coronavirus 2 according to the emerging variant: a nationwide study from February 2020 to June 2022, including comparison with vaccinated populations","volume":"24","author":"Ryu","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2025.102698_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.01.017","article-title":"Case fatality rates of COVID-19 during epidemic periods of variants of concern: a meta-analysis by continents","volume":"141","author":"Xia","year":"2024","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiph.2025.102698_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10654-021-00787-9","article-title":"Over- and under-estimation of COVID-19 deaths","volume":"36","author":"Ioannidis","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jiph.2025.102698_bib9","unstructured":"COVID-19 Forecasting Team. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. Lancet 2023, 401. pp. 833\u2013842. https:\/\/doi.org\/10.1016\/S0140-6736(22)02465-5.."},{"key":"10.1016\/j.jiph.2025.102698_bib10","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1038\/s41467-020-18272-4","article-title":"Substantial underestimation of SARS-CoV-2 infection in the United States","volume":"11","author":"Wu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiph.2025.102698_bib11","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3390\/v14091877","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in tyrol, austria: updated analysis involving 22,607 blood donors covering the period October 2021 to April 2022","volume":"14","author":"Seekircher","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jiph.2025.102698_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/vaccines12030284","article-title":"Anti-SARS-CoV-2 IgG seroprevalence in Tyrol, Austria, among 28,768 blood donors between May 2022 and March 2023","volume":"12","author":"Siller","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.jiph.2025.102698_bib13","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/v14030568","article-title":"Seroprevalence, waning and correlates of anti-SARS-CoV-2 IgG antibodies in Tyrol, Austria: large-scale study of 35,193 Blood Donors Conducted between June 2020 and September 2021","volume":"14","author":"Siller","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jiph.2025.102698_bib14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1473-3099(22)00069-X","article-title":"SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020\u201321","volume":"22","author":"Cohen","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiph.2025.102698_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2471\/BLT.20.265892","article-title":"Infection fatality rate of COVID-19 inferred from seroprevalence data","volume":"99","author":"Ioannidis","year":"2021","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jiph.2025.102698_bib16","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1038\/s41598-024-57238-0","article-title":"Estimating actual SARS-CoV-2 infections from secondary data","volume":"14","author":"Rauch","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2025.102698_bib17","doi-asserted-by":"crossref","unstructured":"COVID-19 Forecasting Team. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis. Lancet 2022;399:1469\u20131488. https:\/\/doi.org\/10.1016\/S0140-6736(21)02867-1.","DOI":"10.1016\/S0140-6736(21)02867-1"},{"key":"10.1016\/j.jiph.2025.102698_bib18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1186\/s12889-021-11127-7","article-title":"Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany","volume":"21","author":"Staerk","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jiph.2025.102698_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.114655","article-title":"Age-stratified infection fatality rate of COVID-19 in the non-elderly population","volume":"216","author":"Pezzullo","year":"2023","journal-title":"Environ Res"},{"key":"10.1016\/j.jiph.2025.102698_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1126\/science.abc3517","article-title":"Estimating the burden of SARS-CoV-2 in France","volume":"369","author":"Salje","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jiph.2025.102698_bib21","article-title":"Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: a nationwide serosurveillance study","volume":"21","author":"Erikstrup","year":"2022","journal-title":"Lancet Reg Health \u2013 Eur"},{"key":"10.1016\/j.jiph.2025.102698_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijid.2022.04.029","article-title":"Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa","volume":"120","author":"Liu","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiph.2025.102698_bib23","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/s41467-024-47199-3","article-title":"The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England","volume":"15","author":"Ward","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiph.2025.102698_bib24","article-title":"Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality","volume":"17","author":"Marziano","year":"2023","journal-title":"Influenza Other Respir Virus"},{"key":"10.1016\/j.jiph.2025.102698_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002118","article-title":"Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England","volume":"21","author":"Eales","year":"2023","journal-title":"PLOS Biol"},{"key":"10.1016\/j.jiph.2025.102698_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010554","article-title":"Novel methods for estimating the instantaneous and overall COVID-19 case fatality risk among care home residents in England","volume":"18","author":"Overton","year":"2022","journal-title":"PLOS Comput Biol"},{"key":"10.1016\/j.jiph.2025.102698_bib27","unstructured":"Total COVID-19 tests per 1,000 people. Our World in Data 2024. \u3008https:\/\/ourworldindata.org\/grapher\/full-list-cumulative-total-tests-per-thousand?country=IND\u223cIDN\u223cITA\u223cZAF\u223cKOR\u223cUSA\u223cDNK\u223cNZL\u223cCAN\u223cAUT\u223cAFG\u223cALB\u223cDZA\u223cAND\u223cAGO\u223cAIA\u223cATG\u223cARG\u223cARM\u223cABW\u3009 (accessed May 10, 2024)."},{"key":"10.1016\/j.jiph.2025.102698_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14136","article-title":"Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals from Austria","volume":"54","author":"Chalupka","year":"2024","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.jiph.2025.102698_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13520","article-title":"SARS-CoV-2 re-infection risk in Austria","volume":"51","author":"Pilz","year":"2021","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.jiph.2025.102698_bib30","unstructured":"AGES. AGES Dashboard COVID19 2023. \u3008https:\/\/covid19-dashboard.ages.at\/\u3009 (accessed June 28, 2023)."},{"key":"10.1016\/j.jiph.2025.102698_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13906","article-title":"Does natural and hybrid immunity obviate the need for frequent vaccine boosters against SARS-CoV-2 in the endemic phase?","volume":"53","author":"Pilz","year":"2023","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.jiph.2025.102698_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taac109","article-title":"Duration of immune protection of SARS-CoV-2 natural infection against reinfection","volume":"29","author":"Chemaitelly","year":"2022","journal-title":"J Travel Med"},{"key":"10.1016\/j.jiph.2025.102698_bib33","unstructured":"Betreuungs- und Pflegedienste. STATISTIK AUSTRIA 2024. \u3008https:\/\/www.statistik.at\/statistiken\/bevoelkerung-und-soziales\/sozialleistungen\/betreuungs-und-pflegedienste\u3009 (accessed July 12, 2024)."},{"key":"10.1016\/j.jiph.2025.102698_bib34","unstructured":"R Core Team.: A Language and Environment for Statistical Computing n.d."},{"key":"10.1016\/j.jiph.2025.102698_bib35","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2021061","article-title":"The age-standardized incidence, mortality, and case fatality rates of COVID-19 in 79 countries: a cross-sectional comparison and their correlations with associated factors","volume":"43","author":"Hong","year":"2021","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.jiph.2025.102698_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12016-022-08921-5","article-title":"Risk and protective factors for COVID-19 morbidity, severity, and mortality","volume":"64","author":"Zhang","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jiph.2025.102698_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13423","article-title":"Global perspective of COVID-19 epidemiology for a full-cycle pandemic","volume":"50","author":"Ioannidis","year":"2020","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.jiph.2025.102698_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/bjd.20093","article-title":"Ultraviolet A radiation and COVID-19 deaths in the USA with replication studies in England and Italy","volume":"185","author":"Cherrie","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jiph.2025.102698_bib39","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s43630-023-00373-w","article-title":"Linkages between COVID-19, solar UV radiation, and the Montreal protocol","volume":"22","author":"Bernhard","year":"2023","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.jiph.2025.102698_bib40","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.3390\/ijerph18084201","article-title":"A Longitudinal seroprevalence study evaluating infection control and prevention strategies at a large tertiary care center with low COVID-19 incidence","volume":"18","author":"Schubert","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jiph.2025.102698_bib41","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00508-021-01963-3","article-title":"Prevalence of SARS-CoV-2 antibodies in healthy blood donors from the state of Tyrol, Austria, in summer 2020","volume":"133","author":"Siller","year":"2021","journal-title":"Wien Klin Woche"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T18:45:48Z","timestamp":1744483548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1876034125000474"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102698","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 case fatality rate and infection fatality rate from 2020 to 2023: Nationwide analysis in Austria","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102698"}}